535 related articles for article (PubMed ID: 19596430)
1. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
2. Lecithin/chitosan nanoparticles for transdermal delivery of melatonin.
Hafner A; Lovrić J; Pepić I; Filipović-Grčić J
J Microencapsul; 2011; 28(8):807-15. PubMed ID: 22117177
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model.
Hafner A; Lovrić J; Romić MD; Juretić M; Pepić I; Cetina-Čižmek B; Filipović-Grčić J
Eur J Pharm Sci; 2015 Jul; 75():142-50. PubMed ID: 25869457
[TBL] [Abstract][Full Text] [Related]
4. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term stability of lyophilised melatonin-loaded lecithin/chitosan nanoparticles.
Hafner A; Dürrigl M; Pepić I; Filipović-Grčić J
Chem Pharm Bull (Tokyo); 2011; 59(9):1117-23. PubMed ID: 21881255
[TBL] [Abstract][Full Text] [Related]
6. Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile.
Nafee N; Schneider M; Schaefer UF; Lehr CM
Int J Pharm; 2009 Nov; 381(2):130-9. PubMed ID: 19450671
[TBL] [Abstract][Full Text] [Related]
7. Formation of biocompatible nanoparticles via the self-assembly of chitosan and modified lecithin.
Chuah AM; Kuroiwa T; Ichikawa S; Kobayashi I; Nakajima M
J Food Sci; 2009; 74(1):N1-8. PubMed ID: 19200109
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
10. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.
Grenha A; Grainger CI; Dailey LA; Seijo B; Martin GP; Remuñán-López C; Forbes B
Eur J Pharm Sci; 2007 Jun; 31(2):73-84. PubMed ID: 17408932
[TBL] [Abstract][Full Text] [Related]
11. Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake.
Barbieri S; Sonvico F; Como C; Colombo G; Zani F; Buttini F; Bettini R; Rossi A; Colombo P
J Control Release; 2013 May; 167(3):276-83. PubMed ID: 23428841
[TBL] [Abstract][Full Text] [Related]
12. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
13. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
14. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies.
Bhatta RS; Chandasana H; Chhonker YS; Rathi C; Kumar D; Mitra K; Shukla PK
Int J Pharm; 2012 Aug; 432(1-2):105-12. PubMed ID: 22569234
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
[TBL] [Abstract][Full Text] [Related]
16. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
17. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
[TBL] [Abstract][Full Text] [Related]
19. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
[TBL] [Abstract][Full Text] [Related]
20. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin.
Senyiğit T; Sonvico F; Barbieri S; Ozer O; Santi P; Colombo P
J Control Release; 2010 Mar; 142(3):368-73. PubMed ID: 19932722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
